MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NewAmsterdam Pharma (NAMS) Ownership - Who owns NewAmsterdam Pharma?
Profile
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.85B
P/E Ratio
N/A
Total Cash
422.73M
Projected Growth
N/A
Total Debt
506K
Revenue
33.59M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.95
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price
Fundamentals
NAMS
Capitalization
2.85B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
423M
Total Cash/Share
3.95
Total Debt
506K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
33.6M
ROE
N/A
Book Value
379M
P/B Ratio
7.52
Cash Flow
N/A
Earnings
-2.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11.4M
Current Ratio
10.61
Current Revenue Per Employee
469532.25
Dividends Per Share - Security
N/A
EBITDA
-180.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-45.29
Shares Held By Institutions
1.26B
Shares Outstanding - Current
107M
Total Liabilities
60.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
138.227
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com